BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27805811)

  • 21. TREK Channel Family Activator with a Well-Defined Structure-Activation Relationship for Pain and Neurogenic Inflammation.
    Qiu Y; Huang L; Fu J; Han C; Fang J; Liao P; Chen Z; Mo Y; Sun P; Liao D; Yang L; Wang J; Zhang Q; Liu J; Liu F; Liu T; Huang W; Yang H; Jiang R
    J Med Chem; 2020 Apr; 63(7):3665-3677. PubMed ID: 32162512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Pharmacology of K
    Decher N; Rinné S; Bedoya M; Gonzalez W; Kiper AK
    Cell Physiol Biochem; 2021 Mar; 55(S3):87-107. PubMed ID: 33667333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in expression of some two-pore domain potassium channel genes (KCNK) in selected brain regions of developing mice.
    Aller MI; Wisden W
    Neuroscience; 2008 Feb; 151(4):1154-72. PubMed ID: 18222039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of TREK currents by the neuroprotective agent riluzole in mouse sympathetic neurons.
    Cadaveira-Mosquera A; Ribeiro SJ; Reboreda A; Pérez M; Lamas JA
    J Neurosci; 2011 Jan; 31(4):1375-85. PubMed ID: 21273422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ca2+ and K+ channels of normal human adrenal zona fasciculata cells: properties and modulation by ACTH and AngII.
    Enyeart JJ; Enyeart JA
    J Gen Physiol; 2013 Aug; 142(2):137-55. PubMed ID: 23858003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscarinic modulation of TREK currents in mouse sympathetic superior cervical ganglion neurons.
    Rivas-Ramírez P; Cadaveira-Mosquera A; Lamas JA; Reboreda A
    Eur J Neurosci; 2015 Jul; 42(2):1797-807. PubMed ID: 25899939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of GABA
    Chang YT; Ling J; Gu JG
    Mol Pain; 2021; 17():17448069211042963. PubMed ID: 34461754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher expression of KCNK10 (TREK-2) K
    Choi SW; Woo J; Park KS; Ko J; Jeon YK; Choi SW; Yoo HY; Kho I; Kim TJ; Kim SJ
    Pflugers Arch; 2021 Apr; 473(4):659-671. PubMed ID: 33586023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologically reversible, loss of function mutations in the TM2 and TM4 inner pore helices of TREK-1 K2P channels.
    Al-Moubarak E; Veale EL; Mathie A
    Sci Rep; 2019 Aug; 9(1):12394. PubMed ID: 31455781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential modulation of TWIK-related K
    Kim HJ; Woo J; Nam Y; Nam JH; Kim WK
    Eur J Pharmacol; 2016 Nov; 791():686-695. PubMed ID: 27568832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-Pore Domain Potassium Channels as Drug Targets: Anesthesia and Beyond.
    Mathie A; Veale EL; Cunningham KP; Holden RG; Wright PD
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():401-420. PubMed ID: 32679007
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Wiedmann F; Schlund D; Faustino F; Kraft M; Ratte A; Thomas D; Katus HA; Schmidt C
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential phosphorylation mediates receptor- and kinase-induced inhibition of TREK-1 background potassium channels.
    Murbartián J; Lei Q; Sando JJ; Bayliss DA
    J Biol Chem; 2005 Aug; 280(34):30175-84. PubMed ID: 16006563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular modulation of TREK-2 activity with nanobodies provides insight into the mechanisms of K2P channel regulation.
    Rödström KEJ; Cloake A; Sörmann J; Baronina A; Smith KHM; Pike ACW; Ang J; Proks P; Schewe M; Holland-Kaye I; Bushell SR; Elliott J; Pardon E; Baukrowitz T; Owens RJ; Newstead S; Steyaert J; Carpenter EP; Tucker SJ
    Nat Commun; 2024 May; 15(1):4173. PubMed ID: 38755204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-pore potassium channel TREK-1 (K2P2.1) regulates NLRP3 inflammasome activity in macrophages.
    Immanuel CN; Teng B; Dong BE; Gordon EM; Luellen C; Lopez B; Harding J; Cormier SA; Fitzpatrick EA; Schwingshackl A; Waters CM
    Am J Physiol Lung Cell Mol Physiol; 2024 Mar; 326(3):L367-L376. PubMed ID: 38252657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of the human detrusor to stretch is regulated by TREK-1, a two-pore-domain (K2P) mechano-gated potassium channel.
    Lei Q; Pan XQ; Chang S; Malkowicz SB; Guzzo TJ; Malykhina AP
    J Physiol; 2014 Jul; 592(14):3013-30. PubMed ID: 24801307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A splice variant of the two-pore domain potassium channel TREK-1 with only one pore domain reduces the surface expression of full-length TREK-1 channels.
    Rinné S; Renigunta V; Schlichthörl G; Zuzarte M; Bittner S; Meuth SG; Decher N; Daut J; Preisig-Müller R
    Pflugers Arch; 2014 Aug; 466(8):1559-70. PubMed ID: 24196565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imiquimod enhances excitability of dorsal root ganglion neurons by inhibiting background (K(2P)) and voltage-gated (K(v)1.1 and K(v)1.2) potassium channels.
    Lee J; Kim T; Hong J; Woo J; Min H; Hwang E; Lee SJ; Lee CJ
    Mol Pain; 2012 Jan; 8():2. PubMed ID: 22233604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermosensitivity of the two-pore domain K+ channels TREK-2 and TRAAK.
    Kang D; Choe C; Kim D
    J Physiol; 2005 Apr; 564(Pt 1):103-16. PubMed ID: 15677687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus.
    Kim EJ; Kwon OS; Hur CG; Nyiramana MM; Lee DK; Hong SG; Han J; Kang D
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.